← SynDRA
IRL-2500
SynDRA canonical compound SYN1948716 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EDNRB |
|---|
| Mechanism of action | endothelin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- endothelin receptor antagonist
Cross-references
Synonyms
- IRL 2500
- IRL2500
- CHEMBL72410
- (2S)-2-[[(2R)-2-[(3,5-dimethylbenzoyl)-methylamino]-3-(4-phenylphenyl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid
- Tocris-1838
- AC1NSK6K
- SCHEMBL7444422
- GTPL3887
- CTK8E7373
- DTXSID20415511
- MolPort-003-983-837
- ZINC1891205
- BDBM50071433
- AKOS024456806
- NCGC00025309-02
- NCGC00025309-01
- RT-013358
- B6872
- A-360
- I-190
- SR-01000597543
- J-010557
- SR-01000597543-1
- N-3-[1,1'-Biphenyl]-4-yl-N-(3,5-dimethylbenzoyl)-N-methyl-D-alanyl-L-tryptophan
Look up IRL-2500 in the interactive SynDRA portal →